1644600-79-2
Chemical Structure
S65487
Synonym(s): VOB560
- CAS No.: 1644600-79-2
- Formula:C41H41ClN6O4
- Molecular Weight:717.26
IUPAC Name: (S)-5-(5-chloro-2-(3-(morpholinomethyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)phenyl)-N-(5-cyano-1,2-dimethyl-1H-pyrrol-3-yl)-N-(4-hydroxyphenyl)-1,2-dimethyl-1H-pyrrole-3-carboxamide
InChIKey: VNNWQLOUMFCVJD-XIFFEERXSA-N
SMILES: O=C(C1=C(C)N(C)C(C2=C(C=CC(Cl)=C2)C(N3[C@@H](CC4=CC=CC=C4C3)CN5CCOCC5)=O)=C1)N(C6=CC=C(C=C6)O)C7=C(C)N(C)C(C#N)=C7
Biological Activity: S65487 (VOB560), a potent and selective BCL-2 inhibitor, is a proagent of S55746. S65487 is also active on BCL-2 mutations, such as G101V and D103Y. S65487 has poor affinity with MCL-1, BFL-1 and BCL-XL. S65487 induces apoptosis and has anticaner activities[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
S65487 | 99.91% | S65487 (VOB560), a potent and selective BCL-2 inhibitor, is a proagent of S55746. S65487 is also active on BCL-2 mutations, such as G101V and D103Y. S65487 has poor affinity with MCL-1, BFL-1 and BCL-XL. S65487 induces apoptosis and has anticaner activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.99
HY-138697BS65487 hydrochloride -
Similarity Score 0.95
HY-138697AS65487 sulfate -
Similarity Score 0.77
HY-168983Lonitoclax -
Similarity Score 0.67
HY-117288S55746 -
Similarity Score 0.67
HY-117288AS55746 hydrochloride -
Similarity Score 0.46
HY-118308AHN-683 -
Similarity Score 0.45
HY-154984JET-209 -
Similarity Score 0.45
HY-128607Mcl1-IN-9 -
Similarity Score 0.45
HY-159905HPK1-IN-54 -
Explore the MedChemAI to find more analogs
References
- [1]. Arnaud Le Tiran, et al. Abstract 1276: Identification of S65487/VOB560 as a potent and selective intravenous 2nd-generation BCL-2 inhibitor active in wild-type and clinical mutants resistant to Venetoclax. Cancer Research. July 2021.
- [2]. American Association for Cancer Research, AACR. 2021.4.10-15.